FAQ: Menopause Benefits 

For two decades, HRT, a hormone therapy which replaces estrogen, carried an FDA black box warning that kept it stigmatized and under-prescribed. A black box warning is the most stringent safety warning the FDA can require from a drug manufacturer, and is added only when substantial clinical data shows the drug can cause severe harm, hospitalization, or death. The FDA removed the black box label from HRT in November 2025.
‍
Yet menopause as a whole continues to be misunderstood, overlooked, or even mismanaged in the workplace: it goes unnamed in performance reviews, unaddressed in benefits packages, and undiscussed between coworkers. It's estimated menopause and its symptoms cause $26.6 billion in costs due to productivity, absenteeism and medical costs, according to the Mayo Clinic.

Unmanaged menopause already shows up in attrition, productivity, and engagement data. HR professionals cite real career consequences tied to menopause, including loss of confidence, reduced productivity, and decreased engagement. When those costs stay beneath the black box, they don't disappear — they just stay invisible. They’re mentioned in exit interviews and informal complaints instead of reaching a benefits review or reportable metric.
‍
That invisibility has a real price tag attached to it. The symptom rabbit hole women go through to even get a diagnosis can often cost more than the menopause benefit itself, and that’s just the beginning of their care journey. Plus, HR leaders may miss the direct impact when the care is buried among claims for other specialities. Beyond the medical costs themselves, 49% of women say menopause has directly affected their job performance, and separate research puts the cost of losing an experienced employee to unmanaged, menopause-related attrition well into the tens of thousands of dollars per departure. That cost lands even harder given who's affected: women in this age range are disproportionately represented in senior and leadership roles, where backfilling is slower, more expensive, and comes with a real loss of institutional knowledge. Treating menopause as a business issue means putting a name to that cost before it shows up as a resignation, not after.

Without coordinated care, employees often see multiple providers across endocrinology, gynecology, mental health, and primary care before getting a clear answer — and the data backs this up. Women see an average of seven physicians before being correctly diagnosed with endometriosis, and nearly half see three or more clinicians before any diagnosis at all; up to 70% of women with PCOS don't even know they have it. Each of those visits carries its own claims cost, but because those costs are scattered across categories rather than sitting in one line item, they rarely reach a benefits review.
‍
A third of women (34%) say they've never told anyone at work about their symptoms, and 14% say they're afraid to tell colleagues at all. More broadly, 57% of people believe women aren't well supported through menopause at work, and 59% call it a topic people are still uncomfortable discussing openly. Those numbers hold up even at the leadership level, since many of the people evaluating whether to add this benefit are themselves in or approaching the same transition, and understandably cautious about how personally the business case reads. That's the real cost of an unopened box: it's not just that employees stay quiet, it's that the leaders positioned to fix it can feel boxed in too.

No — HRT is one possible treatment path, not the whole benefit. A comprehensive approach also includes access to specialists, mental health support, nutrition and coaching, and support for the career impact of symptoms, since menopause symptoms extend well beyond what a prescription alone addresses.
‍
This is also where the FDA history connects back to the workplace conversation: the black box warning applied specifically to HRT as a drug, but the stigma it created spilled over onto the entire topic of menopause at work, treatment included. Employers that treat menopause support as "just HRT coverage" are usually still leaving most of the employee's experience, and most of the associated cost, unaddressed.

A comprehensive approach to menopause support includes access to specialists, mental health support, nutrition and coaching, and support for the career impact of symptoms. Time off and flexibility, workplace environment adjustments, medical insurance, access to specialists, and education are all highly valued among employees. Speed of access matters too — long waits to see a menopause-certified specialist delay relief and add to the cost of the diagnostic process before treatment even starts.
‍
Maven provides fully managed, whole-person menopause care, saving employers $1,600 per employee enrolled in the Menopause & Midlife Health program. Members have access to OB-GYN and specialist visits, mental health support, and nutrition coaching — inside the same platform that already supports fertility, maternity, and parenting. 92% of Maven's menopause members report symptom relief, and the platform reaches employees in more than 175 countries. Because it's one platform rather than a new point solution, adding menopause support is typically an extension of an existing relationship rather than a new vendor evaluation.

Only 40% of employers with health insurance include menopause treatment in their benefits package at all, and even where some coverage exists, it's typically limited to a narrow set of medical visits rather than the fuller picture of specialist access, mental health support, and guidance employees say they need. "We have a health plan" and "we have a menopause benefit" are usually two different things.
‍
That gap tends to show up first in access, not paperwork. General plans rarely guarantee timely access to a menopause-certified specialist. In some cases, employees may wait several weeks for an appointment—delaying relief and adding to the cost of the diagnostic process. By the time coverage technically applies, most of the cost and frustration has already happened outside of it. A real menopause benefit is built around getting employees to the right care quickly, not just having a line item that technically qualifies.

A fertility or maternity benefit shows results within a year or two, once someone completes treatment or has a baby. Menopause plays out differently: it lasts a decade or more, so the savings show up gradually, as fewer employees leave, more stay productive, and specialized care keeps them from missing work due to unmanaged symptoms.
‍
If an employer judges the benefit by asking "did this pay for itself in year one?", they'll likely conclude it didn't work, when really it just hasn't finished playing out yet, or the costs associated with menopause care are disguised as other specialities, like nutrition support, for example. A more accurate way to evaluate it is to track those same three outcomes — retention, productivity, and reduced absenteeism — year over year, and expect the numbers to build over time rather than land all at once.

Anchor it to what's already showing up in your own data — attrition, absenteeism, and engagement — even though menopause is rarely named as the cause. Because roughly a quarter of the workforce is in some phase of menopause at any time, and it disproportionately affects employees in senior, hard-to-replace roles, a clear-eyed cost and retention case tends to land better with Finance than an awareness-only pitch.
‍
Pairing peer benchmarking with hard numbers is typically the strongest combination for both HR and Finance stakeholders. And the data says it's a real and growing expectation, not a niche request: 84% of women want more menopause support at work, and 44% of commercially insured women already expect menopause coverage as part of a comprehensive women's health benefit. It's also a competitive factor in hiring: 1 in 10 women say they've declined a job offer specifically because of a lack of menopause support.

Maven treats it as one continuous journey rather than three separate problems, since symptoms and needs shift across each stage.

• In perimenopause, that often means identifying what's happening in the first place — irregular cycles and early symptoms get misread as something else — paired with access to an OB-GYN or menopause-trained specialist who can confirm what's going on.

• Through menopause itself, members get both hormonal and non-hormonal treatment pathways, so care isn't limited to whoever is comfortable with, or a candidate for, HRT.

• Post-menopause, support continues through ongoing symptom management and longer-term health needs, rather than ending once the most visible symptoms taper off.

Underneath all three stages, members have access to the same full specialist mix — OB-GYN care, mental health support, nutrition coaching, and career coaching — plus 24/7 messaging and same-day appointment availability, so nobody's stuck waiting weeks to get a first answer.